← All trials
NCT07025876
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 18, 2023
- Primary completion
- Jun 15, 2024
- Completion date
- Jul 30, 2024
- First posted
- Jun 18, 2025
- Last posted
- Jun 18, 2025
- Enrollment
- 240
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of ChinaLead sponsor
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.